(+)-pilocarpine increases response to substance EXP 6480464 BDKRB2 protein mutant form results in increased susceptibility to Pilocarpine CTD PMID:15196965 (R)-noradrenaline affects response to substance EXP 6480464 BDKRB2 affects the susceptibility to Norepinephrine CTD PMID:12105144 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of BDKRB2 mRNA CTD PMID:28960355 15-acetyldeoxynivalenol increases expression ISO BDKRB2 (Homo sapiens) 6480464 15-acetyldeoxynivalenol results in increased expression of BDKRB2 mRNA CTD PMID:23792671 17beta-estradiol multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BDKRB2 mRNA CTD PMID:19619570 17beta-estradiol increases expression ISO BDKRB2 (Homo sapiens) 6480464 Estradiol results in increased expression of BDKRB2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BDKRB2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of BDKRB2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of BDKRB2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO BDKRB2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of BDKRB2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO BDKRB2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of BDKRB2 mRNA CTD PMID:11489354 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO BDKRB2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BDKRB2 mRNA CTD PMID:19619570 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO BDKRB2 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 3',5'-cyclic GMP multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [icatibant results in decreased activity of BDKRB2 protein] inhibits the reaction [Valsartan results in increased abundance of Cyclic GMP] CTD PMID:16982965 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of BDKRB2 mRNA CTD PMID:25172293 4-amino-2,6-dinitrotoluene affects expression ISO Bdkrb2 (Rattus norvegicus) 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of BDKRB2 mRNA CTD PMID:21346803 4-hydroxycyclophosphamide multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [afimoxifene co-treated with 4-hydroxycyclophosphamide] affects the expression of BDKRB2 mRNA CTD PMID:25833159 5-fluorouracil multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of BDKRB2 mRNA] CTD PMID:15016801 6-oxoprostaglandin F1alpha affects abundance EXP 6480464 BDKRB2 affects the abundance of 6-Ketoprostaglandin F1 alpha CTD PMID:16514058 6-oxoprostaglandin F1alpha multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [kallidin more ... CTD PMID:29775649 6-oxoprostaglandin F1alpha multiple interactions EXP 6480464 PD 123319 affects the reaction [BDKRB2 affects the abundance of 6-Ketoprostaglandin F1 alpha] CTD PMID:16514058 8-Br-cAMP increases expression ISO BDKRB2 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BDKRB2 mRNA CTD PMID:20147733 afimoxifene multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [afimoxifene co-treated with 4-hydroxycyclophosphamide] affects the expression of BDKRB2 mRNA CTD PMID:25833159 aflatoxin B1 increases methylation ISO BDKRB2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of BDKRB2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO BDKRB2 (Homo sapiens) 6480464 Tretinoin results in increased expression of BDKRB2 mRNA CTD PMID:23724009 and PMID:23830798 allyl isothiocyanate multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 BDKRB2 protein promotes the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein] CTD PMID:17571167 amlodipine increases response to substance EXP 6480464 BDKRB2 results in increased susceptibility to Amlodipine CTD PMID:10523327 aristolochic acid A decreases expression ISO BDKRB2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of BDKRB2 mRNA CTD PMID:33212167 atenolol affects response to substance ISO BDKRB2 (Homo sapiens) 6480464 BDKRB2 exon polymorphism affects the susceptibility to Atenolol CTD PMID:12640257 atropine multiple interactions EXP 6480464 BDKRB2 affects the susceptibility to [Propranolol co-treated with Atropine] CTD PMID:10614985 benazepril increases activity EXP 6480464 benazepril results in increased activity of BDKRB2 protein CTD PMID:15339989 benazepril multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [icatibant results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to benazepril CTD PMID:16982965 benzo[a]pyrene multiple interactions EXP 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to BDKRB2 promoter] CTD PMID:19654925 benzo[a]pyrene increases expression ISO BDKRB2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of BDKRB2 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO BDKRB2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of BDKRB2 5' UTR more ... CTD PMID:27901495 and PMID:30157460 bisphenol A decreases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of BDKRB2 mRNA CTD PMID:25181051 and PMID:30816183 calcium atom multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 BDKRB2 protein affects the reaction [KNG1 protein affects the abundance of Calcium] CTD PMID:18054572 calcium atom multiple interactions EXP 6480464 BDKRB2 protein affects the reaction [pyranoprofen inhibits the reaction [KNG1 protein affects the transport of and affects the localization of Calcium]] CTD PMID:16473424 calcium(0) multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 BDKRB2 protein affects the reaction [KNG1 protein affects the abundance of Calcium] CTD PMID:18054572 calcium(0) multiple interactions EXP 6480464 BDKRB2 protein affects the reaction [pyranoprofen inhibits the reaction [KNG1 protein affects the transport of and affects the localization of Calcium]] CTD PMID:16473424 candesartan decreases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 candesartan results in decreased expression of BDKRB2 mRNA CTD PMID:18796534 capsaicin multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 Capsaicin inhibits the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates] CTD PMID:17347322 capsaicin multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 BDKRB2 affects the reaction [Capsaicin results in increased activity of TRPV1 protein] and BDKRB2 affects the reaction [KNG1 protein promotes the reaction [Capsaicin results in increased activity of TRPV1 protein]] CTD PMID:15363968 captopril multiple interactions EXP 6480464 Captopril inhibits the reaction [LEPR protein affects the expression of BDKRB2 protein] CTD PMID:28130181 carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of BDKRB2 mRNA CTD PMID:25554681 carbon nanotube affects expression EXP 6480464 Nanotubes and Carbon affects the expression of BDKRB2 mRNA CTD PMID:23845593 ceruletide increases expression EXP 6480464 Ceruletide results in increased expression of BDKRB2 mRNA CTD PMID:21484880 CGP 52608 multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to BDKRB2 gene] CTD PMID:28238834 chondroitin sulfate multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Chondroitin Sulfates CTD PMID:21436127 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BDKRB2 protein CTD PMID:31874189 cisplatin multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of BDKRB2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO BDKRB2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of BDKRB2 mRNA CTD PMID:27392435 cisplatin decreases response to substance EXP 6480464 BDKRB2 gene mutant form results in decreased susceptibility to Cisplatin CTD PMID:24975837 cisplatin multiple interactions EXP 6480464 BDKRB2 gene mutant form inhibits the reaction [Cisplatin results in increased expression of IL1B mRNA] and BDKRB2 gene mutant form inhibits the reaction [Cisplatin results in increased expression of TNF mRNA] CTD PMID:24975837 cisplatin increases response to substance EXP 6480464 BDKRB2 gene results in increased susceptibility to Cisplatin CTD PMID:24975837 copper(II) sulfate increases expression ISO BDKRB2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of BDKRB2 mRNA CTD PMID:19549813 cyclophosphamide affects expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Cyclophosphamide affects the expression of BDKRB2 mRNA CTD PMID:15576455 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BDKRB2 mRNA CTD PMID:29950665 diallyl trisulfide decreases expression ISO BDKRB2 (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of BDKRB2 mRNA CTD PMID:34995734 dibutyl phthalate increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of BDKRB2 mRNA CTD PMID:21266533 dichlorine multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] results in decreased expression of BDKRB2 mRNA CTD PMID:18636392 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BDKRB2 mRNA CTD PMID:30529165 diquat increases expression EXP 6480464 Diquat results in increased expression of BDKRB2 mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BDKRB2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO BDKRB2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of BDKRB2 mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 BDKRB2 protein affects the reaction [Doxorubicin results in decreased expression of NOS3 protein] more ... CTD PMID:37409694 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BDKRB2 mRNA CTD PMID:37409694 enalapril increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Enalapril results in increased expression of BDKRB2 mRNA and Enalapril results in increased expression of BDKRB2 protein CTD PMID:18190998 fenvalerate increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 fenvalerate results in increased expression of BDKRB2 mRNA CTD PMID:30307764 fonofos increases methylation ISO BDKRB2 (Homo sapiens) 6480464 Fonofos results in increased methylation of BDKRB2 promoter CTD PMID:22847954 formaldehyde decreases expression ISO BDKRB2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of BDKRB2 mRNA CTD PMID:20655997 genistein multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of BDKRB2 mRNA CTD PMID:21782745 gentamycin increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of BDKRB2 mRNA CTD PMID:33387578 Hexamethonium affects response to substance EXP 6480464 BDKRB2 affects the susceptibility to Hexamethonium CTD PMID:10614985 icatibant multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 icatibant binds to and results in decreased activity of BDKRB2 protein more ... CTD PMID:10666510 and PMID:15140628 icatibant multiple interactions EXP 6480464 icatibant binds to and results in decreased activity of BDKRB2 protein and icatibant inhibits the reaction [KNG1 protein modified form binds to BDKRB2 protein] CTD PMID:24975837 and PMID:30685357 icatibant multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Chondroitin Sulfates more ... CTD PMID:10666510 more ... irbesartan affects response to substance ISO BDKRB2 (Homo sapiens) 6480464 BDKRB2 exon polymorphism affects the susceptibility to irbesartan CTD PMID:12640257 lipopolysaccharide multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of BDKRB2 mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO BDKRB2 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of BDKRB2 mRNA CTD PMID:35811015 manganese(II) chloride increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 manganese chloride results in increased expression of BDKRB2 mRNA CTD PMID:28801915 methoxychlor multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of BDKRB2 mRNA CTD PMID:21782745 methoxychlor increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Methoxychlor results in increased expression of BDKRB2 mRNA CTD PMID:21782745 microcystin-LR increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 cyanoginosin LR results in increased expression of BDKRB2 mRNA CTD PMID:34740672 microcystin-LR multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [Dietary Fats co-treated with Cholesterol and Dietary co-treated with cyanoginosin LR] results in increased expression of BDKRB2 mRNA CTD PMID:34740672 N-methyl-4-phenylpyridinium increases expression ISO BDKRB2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BDKRB2 mRNA CTD PMID:24810058 N-Nitrosopyrrolidine increases expression ISO BDKRB2 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in increased expression of BDKRB2 mRNA CTD PMID:32234424 nickel atom increases expression ISO BDKRB2 (Homo sapiens) 6480464 Nickel results in increased expression of BDKRB2 mRNA CTD PMID:25583101 nitric oxide multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [kallidin more ... CTD PMID:29775649 nitroprusside affects response to substance EXP 6480464 BDKRB2 affects the susceptibility to Nitroprusside CTD PMID:10614985 O-methyleugenol increases expression ISO BDKRB2 (Homo sapiens) 6480464 methyleugenol results in increased expression of BDKRB2 mRNA CTD PMID:32234424 ozone multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] results in decreased expression of BDKRB2 mRNA CTD PMID:18636392 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BDKRB2 mRNA CTD PMID:34911549 paracetamol increases expression ISO BDKRB2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of BDKRB2 mRNA CTD PMID:29067470 paracetamol increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of BDKRB2 mRNA CTD PMID:33387578 parathion increases methylation ISO BDKRB2 (Homo sapiens) 6480464 Parathion results in increased methylation of BDKRB2 promoter CTD PMID:22847954 PD123319 multiple interactions EXP 6480464 PD 123319 affects the reaction [BDKRB2 affects the abundance of 6-Ketoprostaglandin F1 alpha] CTD PMID:16514058 perfluorohexanesulfonic acid decreases expression EXP 6480464 perfluorohexanesulfonic acid results in decreased expression of BDKRB2 mRNA CTD PMID:37995155 perindopril affects expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Perindopril affects the expression of BDKRB2 protein CTD PMID:18806609 phenobarbital affects expression ISO BDKRB2 (Homo sapiens) 6480464 Phenobarbital affects the expression of BDKRB2 mRNA CTD PMID:19159669 phenylephrine affects response to substance EXP 6480464 BDKRB2 affects the susceptibility to Phenylephrine CTD PMID:10614985 phenylephrine increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Phenylephrine results in increased expression of BDKRB2 mRNA CTD PMID:18158353 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of BDKRB2 mRNA CTD PMID:23608068 Pranoprofen multiple interactions EXP 6480464 BDKRB2 protein affects the reaction [pyranoprofen inhibits the reaction [KNG1 protein affects the transport of and affects the localization of Calcium]] CTD PMID:16473424 propranolol multiple interactions EXP 6480464 BDKRB2 affects the susceptibility to [Propranolol co-treated with Atropine] CTD PMID:10614985 ramiprilat increases response to substance EXP 6480464 BDKRB2 results in increased susceptibility to ramiprilat CTD PMID:10523327 resveratrol decreases expression ISO BDKRB2 (Homo sapiens) 6480464 resveratrol results in decreased expression of BDKRB2 mRNA and resveratrol results in decreased expression of BDKRB2 protein CTD PMID:18089832 resveratrol multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of BDKRB2 mRNA CTD PMID:23557933 rotenone increases expression ISO BDKRB2 (Homo sapiens) 6480464 Rotenone results in increased expression of BDKRB2 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO BDKRB2 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of BDKRB2 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of BDKRB2 mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BDKRB2 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO BDKRB2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of BDKRB2 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO BDKRB2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of BDKRB2 mRNA CTD PMID:34032870 streptozocin multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Streptozocin CTD PMID:17989505 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of BDKRB2 mRNA CTD PMID:19516248 sulforaphane decreases expression ISO BDKRB2 (Homo sapiens) 6480464 sulforaphane results in decreased expression of BDKRB2 mRNA CTD PMID:31838189 terbufos increases methylation ISO BDKRB2 (Homo sapiens) 6480464 terbufos results in increased methylation of BDKRB2 promoter CTD PMID:22847954 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of BDKRB2 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of BDKRB2 protein CTD PMID:18054572 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of BDKRB2 mRNA CTD PMID:17656681 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BDKRB2 mRNA CTD PMID:29950665 trichloroethene multiple interactions EXP 6480464 BDKRB2 protein results in increased susceptibility to [Trichloroethylene co-treated with Freund's Adjuvant] CTD PMID:30685357 triclosan increases expression ISO BDKRB2 (Homo sapiens) 6480464 Triclosan results in increased expression of BDKRB2 mRNA CTD PMID:30510588 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions EXP 6480464 BDKRB2 affects the susceptibility to [Propranolol co-treated with Atropine] CTD PMID:10614985 valproic acid increases methylation ISO BDKRB2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of BDKRB2 gene CTD PMID:29154799 valproic acid multiple interactions ISO BDKRB2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BDKRB2 mRNA CTD PMID:27188386 valproic acid increases expression ISO BDKRB2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of BDKRB2 mRNA CTD PMID:24383497 and PMID:26272509 valsartan multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [icatibant results in decreased activity of BDKRB2 protein] inhibits the reaction [Valsartan results in increased abundance of Cyclic GMP] and [icatibant results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Valsartan CTD PMID:16982965 vincristine multiple interactions ISO Bdkrb2 (Rattus norvegicus) 6480464 [icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Vincristine CTD PMID:17989505 zinc atom increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of BDKRB2 mRNA CTD PMID:12672911 zinc(0) increases expression ISO Bdkrb2 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of BDKRB2 mRNA CTD PMID:12672911